|
SAGE
|
Sage Therapeutics, Inc.
|
0.55%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.53%
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
0.53%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
0.51%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.51%
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
0.50%
|
US
|
NASDAQ
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
0.49%
|
US
|
NASDAQ
|
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.48%
|
US
|
NASDAQ
|
|
EBS
|
Emergent Biosolutions, Inc.
|
0.47%
|
US
|
NYSE
|
|
NVAX
|
Novavax, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
CDNA
|
CareDx, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
RVMD
|
Revolution Medicines, Inc.
|
0.44%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
0.43%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
0.42%
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
SRNE
|
Sorrento Therapeutics, Inc.
|
0.40%
|
US
|
NASDAQ
|